CRP and colorectal cancer: Additional sensitivity analyses, presented for models for colorectal cancer, involved evaluating the influence of participants with extreme CRP concentrations or lymphocyte counts or with regular aspirin use, but excluding such participants did not affect the HR estimates (Supplementary Table S5).